Pharmacelsus - Preclinical Services

Your Partner for Drug Discovery, Development and Analytical Excellence

For more than 20 years, the GBA Group has been supporting pharmaceutical, biotechnology, cosmetic and chemical industry partners with integrated research, development and analytical services. We provide customized solutions from Hit-to-Lead and Lead Optimization through preclinical development and clinical Phase I and Phase II studies. Our comprehensive portfolio combines ADMET, DMPK and bioanalytical expertise with advanced in vitro, ex vivo and in vivo testing capabilities. We support small and large molecules, peptides, PROTACS, Oligomers and biologics through high-quality bioanalysis, pharmacokinetic studies, biomarker quantification and regulatory-compliant testing. With a consultative, science-driven approach and decades of experience, we help our clients generate reliable data, reduce development risks and accelerate successful product development—from discovery to the clinic.